[Experimental research on Arginine-gingipain A gene vaccine from Porphyromonas gingivalis that prevents peri-implantitis in Beagle dogs]
- PMID: 29595001
- PMCID: PMC7030179
- DOI: 10.7518/hxkq.2018.01.015
[Experimental research on Arginine-gingipain A gene vaccine from Porphyromonas gingivalis that prevents peri-implantitis in Beagle dogs]
Abstract
Objective: This study aims to use Arginine-gingipain A gene vaccine (pVAX1-rgpA) to immunize adult Beagle dogs and to evaluate its effect during peri-implantitis progression and development.
Methods: Plasmid pVAX1-rgpA was constructed. The second and third bilateral mandible premolars of 15 adult Beagle dogs were extracted, and the implants were placed immediately. After 3 months, the animals were randomly divided into groups A, B, and C. Afterward, the animals were immunized thrice with plasmid pVAX1-rgpA, with heat-killed Porphyromonas gingivalis, or pVAX1, respectively. IgG in the serum and secretory IgA (sIgA) in saliva were quantitatively analyzed by enzyme-linked immunosorbent assay before and after 2 weeks of immunization. Peri-implantitis was induced with cotton ligatures fixed around the neck of implants. Probing depth (PD) and bleeding on probing were recorded. All animals were sacrificed after ligaturation for 6 weeks. Decalcified sections with thickness of 50 μm were prepared and dyed with methylene blue to observe the bone phenotype around implants.
Results: Levels of serum IgG and sIgA in saliva were higher in groups A and B after immunization than before the process (P<0.05) and higher than those in group C (P<0.05). However, no difference was observed between groups A and B (P>0.05). At 4 and 6 weeks after ligaturation, PD of the ligatured side in group C was higher than that in groups A and B (P<0.05). On the other hand, no difference was identified between groups A and B (P>0.05). Bone loss in group A was significantly lower than that of the other groups (P<0.05). Abundant inflammatory cells and bacteria were present in the bone loss area around the implants in the three groups, as identified through hard tissue section observation. However, group C presented the most number of inflammatory cells and bacteria in the bone loss area around the implants.
Conclusions: IgG and sIgA can be generated by immunity with rgpA DNA vaccine, which can significantly slow down bone loss during experimental peri-implantitis in dogs.
目的 构建牙龈卟啉单胞菌精氨酸特异性牙龈素基因疫苗pVAX1-rgpA,并对成年犬进行免疫接种,观察该疫苗在防治种植体周围炎发生发展中的作用。方法 构建真核表达质粒pVAX1-rgpA。拔除15只成年犬下颌双侧第二、三前磨牙,随机即刻植入种植体。3个月后,实验犬随机均分成A、B、C组,分别接种重组质粒pVAX1-rgpA、热失活牙龈卟啉单胞菌、空白质粒pVAX1,连续接种3次。接种开始前、接种结束2周后采用酶联免疫吸附试验检测血清IgG和唾液分泌型IgA(sIgA)含量。随机选取一侧采用丝线结扎法构建种植体周围炎,并检测种植体周探诊深度(PD)和探诊出血指数(BOP)。结扎6周后处死所有动物,制作50 μm厚的硬组织切片,亚甲基蓝染色后观察种植体周骨丧失程度。结果 A、B组动物免疫后,IgG、sIgA抗体较未免疫前明显增高(P<0.05),同时较C组升高(P<0.05),但A、B组间差异无统计学意义(P>0.05)。丝线结扎第4和6周时,C组结扎侧的PD明显高于A、B组(P<0.05),A、B组间差异无明显统计学意义(P>0.05)。A组结扎侧骨丧失量明显小于其他两组(P<0.05)。硬组织切片可见,各组种植体周骨丧失区均有大量的炎症细胞和细菌存在,C组结扎侧最严重。结论 精氨酸特异性牙龈素(rgpA)基因疫苗产生的IgG和sIgA,能有效减弱犬种植体周围炎的骨丧失量。.
Keywords: Arginine-gingipains; Porphyromonas gingivalis; dental implant; gene vaccine; peri-implantitis.
Figures




Similar articles
-
rgpA DNA vaccine induces antibody response and prevents alveolar bone loss in experimental peri-implantitis.J Periodontol. 2013 Jun;84(6):850-6. doi: 10.1902/jop.2012.120251. Epub 2012 Aug 23. J Periodontol. 2013. PMID: 22917113
-
kgp, rgpA, and rgpB DNA vaccines induce antibody responses in experimental peri-implantitis.J Periodontol. 2014 Nov;85(11):1575-81. doi: 10.1902/jop.2014.140240. Epub 2014 Jun 12. J Periodontol. 2014. PMID: 24921431
-
rgpA-Engineered/Functionalized DNA Vaccine as a Novel Prophylactic Vaccination to Prevent Porphyromonas gingivalis-Induced Periodontitis: An in Vivo Study.Discov Med. 2024 Feb;36(181):355-365. doi: 10.24976/Discov.Med.202436181.33. Discov Med. 2024. PMID: 38409840
-
Porphyromonas gingivalis gingipains: the molecular teeth of a microbial vampire.Curr Protein Pept Sci. 2003 Dec;4(6):409-26. doi: 10.2174/1389203033487009. Curr Protein Pept Sci. 2003. PMID: 14683427 Review.
-
Gingipains as candidate antigens for Porphyromonas gingivalis vaccine.Keio J Med. 2003 Sep;52(3):158-62. doi: 10.2302/kjm.52.158. Keio J Med. 2003. PMID: 14529148 Review.
References
-
- Corbella S, Del Fabbro M, Taschieri S, et al. Clinical evaluation of an implant maintenance protocol for the prevention of peri-implant diseases in patients treated with immediately loaded full-arch rehabilitations[J] Int J Dent Hyg. 2011;9(3):216–222. - PubMed
-
- Paramonov N, Rangarajan M, Hashim A, et al. Structural analysis of a novel anionic polysaccharide from Porphyromonas gingivalis strain W50 related to Arg-gingipainglycans[J] Mol Microbiol. 2005;58(3):847–863. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous